49 results
Page 2 of 3
8-K
EX-99.1
jlbfllbac
8 Nov 19
Recro Pharma Reports Third Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
gme9 gdqcyd5wk
31 Oct 19
Other Events
10:10am
8-K
EX-99.1
ij9m0b8m2a4sptdis
8 Aug 19
Recro Pharma Reports Second Quarter 2019 Financial Results
7:58am
8-K
EX-99.1
67qv jxs3x3e
10 May 19
Recro Pharma Reports First Quarter 2019 Financial Results
7:05am
8-K
EX-10.1
27jr55 4kb9ce1c
18 Apr 19
Entry into a Material Definitive Agreement
6:05am
8-K
EX-99.1
p422c3ga
5 Apr 19
Cost Associated with Exit or Disposal Activities
4:01pm
8-K
EX-99.1
oyi7 mh6dlf0
28 Mar 19
Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors
6:05am
8-K
EX-99.1
ywgc3p5huzlfki
19 Feb 19
Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018
7:05am
8-K
EX-99.1
q9r ruisade7x1
10 Dec 18
Other Events
2:07pm
8-K
EX-99.1
0ccutejxifg6ctf4d
7 Nov 18
Recro Pharma Reports Third Quarter 2018 Financial Results
7:06am
8-K
EX-99.1
572xw uswvd
9 Oct 18
Recro Pharma Announces PDUFA Date for IV Meloxicam
6:07am
8-K
EX-99.1
3p50k kadjaaql2qfv
1 Oct 18
Recro Announces Expansion of CDMO Service Capabilities
12:00am
8-K
EX-99.1
ksjpqd
7 Aug 18
Recro Pharma Reports Second Quarter 2018 Financial Results
7:05am
8-K
EX-99.1
cu418i
9 May 18
Recro Pharma Reports First Quarter 2018 Financial Results
7:01am
8-K
EX-99.1
crm5ks7r
7 May 18
Other Events
9:41am
8-K
EX-99.1
03nr8uumoafgnni6k1
30 Apr 18
Other Events
7:15am